Rachel Moseley is principal academic in psychology at Bournemouth University in the United Kingdom. Her research centers around issues that autistic adults face, including mental ill-health, suicidality, self-injury, aging and late diagnosis. She also investigates aspects of cognition and social communication in autistic people and how these differ depending on personal characteristics, such as sex.
Rachel Moseley
Principal academic
Bournemouth University
From this contributor
Autism and menopause: Q&A with Rachel Moseley and Julie Turner-Cobb
Menopause poses significant challenges for autistic people, according to a small survey published in 2020 — the first to explore the transition among people with autism traits.
Autism and menopause: Q&A with Rachel Moseley and Julie Turner-Cobb
Autism and eating disorders may have an emotional connection
Eating disorders have the highest mortality rates of any kinds of mental illness. They don’t discriminate, affecting people of all ethnicities, sexualities, gender identities, ages and backgrounds.
Autism and eating disorders may have an emotional connection
Explore more from The Transmitter
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.